SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00078



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00078_19T 1 Human HLA-DQA10101-DQB10201,HLA-DQA10501-DQB10501,DRB1_0101,DRB1_0301
SYSMHC00078_42RF 1 Human HLA-DQA10101-DQB10202,HLA-DQA10303-DQB10501,DRB1_0102,DRB1_0405
SYSMHC00078_42RS 1 Human HLA-DQA10101-DQB10202,HLA-DQA10303-DQB10501,DRB1_0102,DRB1_0405
SYSMHC00078_51AL 1 Human HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10602,DRB1_0401,DRB1_1501
SYSMHC00078_51BR 2 Human HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10602,DRB1_0401,DRB1_1501
SYSMHC00078_55A3 1 Human HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302
SYSMHC00078_55B3 1 Human HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302
SYSMHC00078_55A7 2 Human HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302
SYSMHC00078_70 1 Human HLA-DQA10103-DQB10302,HLA-DQA10301-DQB10603,DRB1_0401,DRB1_1301
SYSMHC00078_86B 2 Human HLA-DQA10301-DQB10302,DRB1_0404
SYSMHC00078_92B 1 Human HLA-DQA10102-DQB10301,HLA-DQA10303-DQB10602,DRB1_0401,DRB1_1501
SYSMHC00078_112 1 Human HLA-DQA10101-DQB10501
SYSMHC00078_422_CD45N 1 Human HLA-DQA10101-DQB10202,HLA-DQA10303-DQB10501,DRB1_0102,DRB1_0405
SYSMHC00078_422_CD45P 1 Human HLA-DQA10101-DQB10202,HLA-DQA10303-DQB10501,DRB1_0102,DRB1_0405
SYSMHC00078_51AL_SC 3 Fusobacterium nucleatum HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10602,DRB1_0401,DRB1_1501
SYSMHC00078_51AL_CIITA_LPL 3 Fusobacterium nucleatum HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10602,DRB1_0401,DRB1_1501
SYSMHC00078_51AL_SC_LPL 3 Fusobacterium nucleatum HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10602,DRB1_0401,DRB1_1501
SYSMHC00078_51A3_SC 3 Staphylococcus caprae HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302
SYSMHC00078_51A3_CIITA 3 Staphylococcus caprae HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302
SYSMHC00078_51AL_SC_Animalis 3 Staphylococcus caprae HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302
SYSMHC00078_51AL_CIITA_Animalis 3 Staphylococcus caprae HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302
SYSMHC00078_58A 3 Staphylococcus capitis DRB1_0101,DRB1_0301
SYSMHC00078_721221_fuso 3 Fusobacterium nucleatum DRB1_0102
SYSMHC00078_721221_A 3 Fusobacterium nucleatum DRB1_0102
SYSMHC00078_IHW 3 Fusobacterium nucleatum HLA-DQA10201-DQB10303,HLA-DQA10301-DQB10302,HLA-DPA10103-DPB10402,HLA-DPA10103-DPB10401,DRB1_0701,DRB1_0404



Detailed view of sample SYSMHC00078_51A3_SC



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00078 SYSMHC00078_51A3_SC QEP2_11756_YSA_466_1_060820.raw Staphylococcus caprae In vitro Melanoma 55A3 cell suspension Melanoma class II HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302 PXD022150 native Immunoaffinity Q-Exactive no DDA HCD 5-28%(0.1% FA in ACN) 120 1
SYSMHC00078 SYSMHC00078_51A3_SC QEP2_11756_YSA_464_1_060820.raw Staphylococcus caprae In vitro Melanoma 55A3 cell suspension Melanoma class II HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302 PXD022150 native Immunoaffinity Q-Exactive no DDA HCD 5-28%(0.1% FA in ACN) 120 2
SYSMHC00078 SYSMHC00078_51A3_SC QEP2_11756_YSA_465_1_060820.raw Staphylococcus caprae In vitro Melanoma 55A3 cell suspension Melanoma class II HLA-DQA10102-DQB10302,HLA-DQA10301-DQB10604,DRB1_0404,DRB1_1302 PXD022150 native Immunoaffinity Q-Exactive no DDA HCD 5-28%(0.1% FA in ACN) 120 3